These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15512961)

  • 1. Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice.
    Osorio Y; Cai S; Hofman FM; Brown DJ; Ghiasi H
    Curr Eye Res; 2004; 29(2-3):145-51. PubMed ID: 15512961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mice with anti-CD86 mAb reduces CD8+ T cell-mediated CTL activity and enhances ocular viral replication in HSV-1-infected mice.
    Osorio Y; Cai S; Ghiasi H
    Ocul Immunol Inflamm; 2005; 13(2-3):159-67. PubMed ID: 16019675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mice.
    Allen SJ; Mott KR; Ljubimov AV; Ghiasi H
    Virology; 2010 Mar; 399(1):11-22. PubMed ID: 20079918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
    Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
    Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
    J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.
    Ghiasi H; Wechsler SL; Kaiwar R; Nesburn AB; Hofman FM
    J Virol; 1995 Jan; 69(1):334-40. PubMed ID: 7983727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
    Osorio Y; La Point SF; Nusinowitz S; Hofman FM; Ghiasi H
    Exp Neurol; 2005 May; 193(1):1-18. PubMed ID: 15817260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
    Gangappa S; Deshpande SP; Rouse BT
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):453-9. PubMed ID: 10670475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL; Tumpey TM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
    Banerjee K; Biswas PS; Rouse BT
    J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis.
    Maertzdorf J; Verjans GM; Remeijer L; van der Kooi A; Osterhaus AD
    J Infect Dis; 2003 Feb; 187(4):550-8. PubMed ID: 12599071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.
    Ghiasi H; Perng GC; Nesburn AB; Wechsler SL
    Virus Res; 2000 Jul; 68(2):137-44. PubMed ID: 10958985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8
    Jaggi U; Wang S; Tormanen K; Matundan H; Ljubimov AV; Ghiasi H
    Front Immunol; 2018; 9():2895. PubMed ID: 30581441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity.
    Mott KR; Chentoufi AA; Carpenter D; BenMohamed L; Wechsler SL; Ghiasi H
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2903-12. PubMed ID: 19168902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.